Sumatriptan Nasal Spray for Acute Migraine
Abstract
A multicenter, randomized, double-blind, placebo-controlled trial of sumatriptan nasal spray (5 mg, 10 mg, and 20 mg) was conducted in 653 adolescents presenting with acute migraine at the Palm Beach Headache Center, Florida; Cleveland Clinic, OH; Michigan Headache Institute, Ann Arbor; and San Antonio Center, TX.
DOI: https://doi.org/10.15844/pedneurbriefs-14-11-3 | Journal eISSN: 2166-6482
Language: English
Page range: 82 - 83
Published on: Nov 1, 2000
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2000 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.